Spectrum Pharmaceuticals, Inc. (SPPI) Tops Q1 EPS by 23c

Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) reported Q1 EPS of $0.01, $0.23 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $40.1 million versus the consensus estimate of $39.49 million.

For earnings history and earnings-related data on Spectrum Pharmaceuticals, Inc. (SPPI) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• JPMorgan Upgrades Amber Enterprises India Ltd (AMBER:IN) to Overweight
• Genco rejects Diana Shipping takeover bid as undervalued